Sigma Healthcare Valuation
| SIG Stock | 2.75 0.06 2.14% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Sigma Healthcare has a current Real Value of USD2.42 per share. The regular price of the company is USD2.75. Our model measures the value of Sigma Healthcare from inspecting the company fundamentals such as Shares Outstanding of 11.54 B, operating margin of 0 %, and Return On Equity of -0.0032 as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 37.8884 | Enterprise Value 31.9 B | Enterprise Value Ebitda 586.8784 | Price Sales 9.0874 | Forward PE 47.1698 |
Overvalued
Today
Please note that Sigma Healthcare's price fluctuation is moderately volatile at this time. Calculation of the real value of Sigma Healthcare is based on 3 months time horizon. Increasing Sigma Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Sigma Healthcare's intrinsic value may or may not be the same as its current market price of 2.75, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.75 | Real 2.42 | Hype 2.75 | Naive 2.8 |
The intrinsic value of Sigma Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sigma Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sigma Healthcare helps investors to forecast how Sigma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sigma Healthcare more accurately as focusing exclusively on Sigma Healthcare's fundamentals will not take into account other important factors: Sigma Healthcare Cash |
|
Sigma Healthcare Total Value Analysis
Sigma Healthcare is at this time forecasted to have takeover price of 31.86 B with market capitalization of 31.63 B, debt of 132.09 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sigma Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.86 B | 31.63 B | 132.09 M |
Sigma Healthcare Investor Information
About 49.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.01. Sigma Healthcare last dividend was issued on the 1st of October 2024. The entity had 1.0418:1 split on the 10th of September 2009. Based on the measurements of operating efficiency obtained from Sigma Healthcare's historical financial statements, Sigma Healthcare is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Sigma Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Sigma implies not a very effective usage of assets in July.Sigma Healthcare Ownership Allocation
Sigma Healthcare shows a total of 11.54 Billion outstanding shares. 30% of Sigma Healthcare outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sigma Healthcare Profitability Analysis
The company reported the revenue of 4.89 B. Net Loss for the year was (13.84 M) with profit before overhead, payroll, taxes, and interest of 227.81 M.About Sigma Healthcare Valuation
The stock valuation mechanism determines Sigma Healthcare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Sigma Healthcare based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sigma Healthcare. We calculate exposure to Sigma Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sigma Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 334.1 M | 253.1 M |
Additional Tools for Sigma Stock Analysis
When running Sigma Healthcare's price analysis, check to measure Sigma Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sigma Healthcare is operating at the current time. Most of Sigma Healthcare's value examination focuses on studying past and present price action to predict the probability of Sigma Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sigma Healthcare's price. Additionally, you may evaluate how the addition of Sigma Healthcare to your portfolios can decrease your overall portfolio volatility.